- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Important, 05-12-2025: Updates
05-12-2025 | 06:05 pm
05-12-2025 | 06:05 pm
Biocon's subsidiary secured tentative US FDA approval for Carbidopa and Levodopa Extended-Release Capsules. This key drug for Parkinson's disease and related conditions clears a path for future market entry, a significant business development.
No comments yet. Be the first to comment!